Sienna Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s primary product candidates from its technological platform are SNA-120 (pegcantratinib), a first-in-class TrkA inhibitor for the topical treatment of psoriasis, as well as the associated pruritus; and SNA-125, a topical JAK3/TrkA inhibitor with the potential to treat various inflammatory conditions, including atopic dermatitis, psoriasis and the associated pruritus. Co.'s second technology platform, Topical Photoparticle Therapy™, utilizes silver particles applied to the skin to direct the light from commercially available lasers to the hair follicle or sebaceous gland to cause selective photothermolysis. We show 12 historical shares outstanding datapoints in our SNNA shares outstanding history coverage, used to compute SNNA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SNNA market cap history over the course of time is important for investors
interested in comparing SNNA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SNNA versus a peer is one thing; comparing
SNNA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SNNA can fluctuate over the course of history.
With this page we aim to empower investors researching SNNA by allowing them to research the SNNA market cap history. |
Free SNNA Email Alerts:
Video: The Importance of Market Cap
